Dr. John Hawboldt
Associate Professor, Cross Appointment to Faculty of Medicine
Phone: 709 777 8777
Please note, with the exception of PharmD students, currently Dr. Hawboldt is not taking graduate students at this time.
2003 - University of Washington, Seattle, WA. Doctor of Pharmacy
1992-1993 - Alberta Children’s Hospital, Calgary, AB. Hospital Pharmacy Residency
- 1992 - University of Saskatchewan, Saskatoon, SK. Bachelor of Science, Pharmacy (with distinction)
My primary area of interest is in pharmacy practice, expanding the role of the pharmacists in Newfoundland and Labrador, medication use management/safety and also antimicrobial stewardship.
I am currently in the process of assisting in the implementation of an antimicrobial stewardship program at Eastern Health, in St. John's, NL.
I also have a strong interest in curriculum development and assessment.
I have had numerous practice sites over the years (medicine, surgery, adult critical care, neonatal critical care, ambulatory care and infectious disease) and am currently affiliated with the Cystic Fibrosis Program of Eastern Health (both adult and pediatric).
I am cross-appointed to the Department of Medicine (Respirology) and the Department of Pharmacy at Eastern Health.
My teaching responsibilities primarily include infectious disease, gastrointestinal and respirology pharmacotherapy.
Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador.
Housser E, Mathews M, Lemessurier J, Young S, Hawboldt J, West R.
Curr Oncol. 2013 Jun;20(3):158-65. doi: 10.3747/co.20.1197.
Real-world challenges to the practice of evidence-based medicine.
McCarthy R, Hawboldt J, Davis E.
Can J Hosp Pharm. 2012 Nov;65(6):465-6. No abstract available.
Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
Bader MS, Twells L, Hawboldt J.
South Med J. 2011 Dec;104(12):789-93. doi: 10.1097/SMJ.0b013e3182387365.
Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic.
Young S, Bishop L, Twells L, Dillon C, Hawboldt J, O'Shea P.
BMC Fam Pract. 2011 Aug 17;12:88. doi: 10.1186/1471-2296-12-88.
Antibiotic administration longer than eight hours after triage and mortality of community-acquired pneumonia in patients with diabetes mellitus.
Bader MS, Abouchehade KA, Yi Y, Haroon B, Bishop LD, Hawboldt J.
Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):881-6. doi: 10.1007/s10096-011-1171-8. Epub 2011 Feb 1.
Management of complicated urinary tract infections in the era of antimicrobial resistance.
Bader MS, Hawboldt J, Brooks A.
Postgrad Med. 2010 Nov;122(6):7-15. doi: 10.3810/pgm.2010.11.2217. Review.
Antibiotic prescribing and antimicrobial resistance.
Bader MS, Hawboldt J.
Postgrad Med. 2010 Jul;122(4):227-9. doi: 10.3810/pgm.2010.07.2192. No abstract available.
Use of evidence-based therapy at discharge for patients with acute myocardial infarction: retrospective audit of medical records.
Young SW, Hawboldt JJ, Pearce NJ.
Can J Hosp Pharm. 2010 May;63(3):207-11.
Pulmonary Infection Due to Mycobacterium malmoense in a Patient with Crohn Disease.
Cowan CD, Hawboldt JJ, Bader M.
Can J Hosp Pharm. 2009 Nov;62(6):496-9. No abstract available.
Survey of Canadian Pharmacists' Responses to Warnings of Potential Interactions Between Ceftriaxone and Calcium in IV Solutions.
Harder CK, Hawboldt JJ.
Can J Hosp Pharm. 2009 Nov;62(6):483-9.
TRUST Surveillance Initiative: antimicrobial resistance among common bacterial respiratory tract pathogens. Commentary.
Bader M, Hawboldt JJ.
Postgrad Med. 2009 Mar;121(2):205-7. doi: 10.3810/pgm.2009.03.1996 No abstract available.
Intramuscular methotrexate-induced aseptic meningitis.
Hawboldt J, Bader M.
Ann Pharmacother. 2007 Nov;41(11):1906-11. Epub 2007 Sep 18.